Amgen launches osteoporosis drug at $21,900 per treatment course

Amgen launched Evenity romosozumab-aqqg in the U.S. at $1,825 per month to treat osteoporosis in postmenopausal

Read the full 164 word article

How to gain access

Continue reading with a
two-week free trial.